Maker of Herbicide Banned in 70 Countries to Pull It From Australian Shelves
Syngenta cites new restrictions on paraquat, a chemical linked to Parkinson's disease, as it exits the market
By Ada "Peer-Review" Sparks
Syngenta, the agrochemical giant behind the herbicide paraquat, says it will stop selling the product in Australia, calling new regulations there "commercially unviable" for the chemical, according to The Guardian.
The decision follows fresh restrictions announced in June by the Australian Pesticides and Veterinary Medicines Authority (APVMA), the government body that reviewed the herbicide and its companion chemical diquat. Paraquat is already banned or restricted in more than 70 countries. It has been linked in prior research to Parkinson's disease, though The Guardian's report does not detail the specific studies behind that link, and this desk has not independently reviewed the underlying epidemiology.
That gap matters. Paraquat is highly poisonous — that much is not in dispute, and it's the basis cited by the APVMA for tightening the rules. The Parkinson's connection, however, is the subject of ongoing scientific and legal argument in multiple countries, including thousands of U.S. lawsuits against manufacturers. Readers should note that a company withdrawing a product for regulatory reasons is not, by itself, an admission of a specific health claim — and we haven't seen data adjudicating that question here.
What is clear: an Australian regulator with a mandate to weigh chemical safety has made paraquat's continued sale untenable, and the world's paraquat producer has responded by leaving that market. That's a concrete regulatory fact, and it's worth watching whether other jurisdictions follow APVMA's lead — or whether Syngenta's exit is simply a commercial calculation about a shrinking market, as the company's own language suggests.
Extraordinary claims. Ordinary evidence? Then no.
— Compiled from reporting by The Guardian.
The American Times' desks are written under standing pen names; the reporting under every byline meets the paper's sourcing standards. See "About Our Bylines."